COVID-19 Vaccine and Children
Vaccine Options for Nemours Children's Patients
In the Delaware Valley: We are providing the Pfizer-BioNTech COVID-19 vaccine to all children and young adults, ages 12 to 21. Schedule now. We track demand for appointments and often add new dates. Please keep checking the link for new appointment dates.
If your child is avoiding COVID-19 vaccination due to a reaction to a medication or vaccine in the past, our Allergy Team can help. Please discuss a referral with your child's primary care provider.
The Delaware Division of Public Health is hosting Pfizer vaccine walk-in hours at five public clinics. No appointments are necessary and clinics are open to Delaware residents age 16 years and older. Clinics are located in Dover, Georgetown, Milford, Seaford and Wilmington. Learn More
Our friends at Madeleine C. Weiser, MD & Associates in Ardmore, Pennsylvania, are opening their COVID-19 vaccine clinics to Nemours Children's patients. Schedule Now . Include the name of your Nemours Children's office in the "Family Physician" field of the registration form.
In Florida: All Florida residents age 12 and older are eligible to receive a COVID-19 vaccine. We encourage parents to schedule your child's COVID-19 vaccination at any Florida community clinic or retail site offering the Pfizer-BioNTech vaccine. All individuals under the age of 18 receiving a vaccine must be accompanied by a guardian and complete a consent form.
Frequently Asked Questions About the COVID-19 Vaccine
The Pfizer vaccine is currently authorized for children age 12 years and up, and has been shown to be safe for that age group. Clinical trials are taking place now to help us learn more about how the vaccines work for younger children.
We are currently offering the vaccine to patients age 12 and older in the Delaware Valley. We encourage Florida families to schedule your eligible child's COVID-19 vaccination at any Florida community clinic or retail site offering the Pfizer-BioNTech vaccine.
In the Delaware Valley: We are working with the state of Delaware to support their efforts to vaccinate health care workers and Delaware residents ages 65+. Our community clinics are by invitation only and appointment only. We do not have an open registration system, but rather are partnering directly with community-based organizations providing services to these two specific populations. For seniors, we are particularly focused on targeting the most vulnerable among those 65+ by working with groups like Nemours SeniorCare and the Ministry of Caring. Those organizations then coordinate the registrations on behalf of their clients.
If you have a question about an appointment that is already scheduled, please email us at CommunityCOVIDVaccinations@nemours.org. Please allow up to two business days for a response. For more information on how to schedule a vaccine appointment through the state of Delaware, please visit https://coronavirus.delaware.gov/vaccine
In Florida: Nemours Children's is not vaccinating adults in Florida.
At this time the Pfizer vaccine has been authorized for children age 12 and up.
Available evidence suggests the COVID-19 vaccine is safe for most pregnant and breastfeeding women, but studies are ongoing. Please consult with your personal physician to determine if the vaccine is safe for you.
The vaccine is given by injecting it into a muscle, usually in an arm or thigh.
For the Pfizer vaccine, two doses are required. Dose 2 should be given 21 days after dose 1.
Vaccinated children who have undergone solid organ transplantation or who are diagnosed with conditions considered to have an equivalent level of immunocompromise may be considered for a third dose of the Pfizer vaccine. The CDC recommends the following individuals be considered for a third dose of an mRNA vaccine If they received it as the first dose:
- Organ transplant recipients taking immunosuppressive therapy
- Recipient of stem cell transplants (CAR-T-cell or hematopoietic) within two years or taking immunosuppressive therapy
- Active/recent cancer treatments for tumors or hematologic malignancies
- Advanced or untreated HIV infection
- Persons taking medications that weaken the immune system — high-dose corticosteroids (i.e., ≥20mg prednisone or equivalent per day), alkylating agents, antimetabolites, transplant-related immunosuppressive drugs, cancer chemotherapeutic agents classified as severely immunosuppressive, TNF blockers, and other biologic agents that are immunosuppressive or immunomodulatory
- Moderate or severe primary immunodeficiency (e.g., DiGeorge, Wiskott-Aldrich syndromes)
Please ask your child's provider if your child should get a third dose.
Most people report no or mild side effects from dose 1 and more noticeable side effects after dose 2. Of those who experienced side effects, the most common include fatigue, headache, soreness at the site of injection or muscle/joint aches. Less than 2% of participants experienced a fever. Most people who experienced side effects said they went away after 48 hours.
No. Having uncontrolled, widespread community spread of COVID-19 would put your family and your entire community at serious risk. The health care system would be overwhelmed to the point that it could not take care of people with COVID-19 or those with any other health needs. Importantly, the risk of getting COVID-19 far outweighs any risk of the vaccine. Unfortunately, “natural immunity” does not last long… there are many cases of people who have already had COVID-19 twice. The best way to stop the pandemic is to follow safety guidelines and get the vaccine when it is your turn.
Yes, the vaccine is recommended for people who have had COVID-19 because natural immunity does not last long and your child can get COVID-19 again, putting themselves and others at risk.
As a children’s health system, we have many patients who are too young to be vaccinated and others who are immunocompromised. To ensure the safety of all who visit us, we require everyone age 2 and older to wear a mask and maintain social distance. We will continue to monitor the latest data and government guidance, and will update our masking policy as information changes.